Lofexidine
CAS No. 31036-80-3
Lofexidine ( —— )
产品货号. M20672 CAS No. 31036-80-3
Lofexidine is a selective α2-receptor agonist Lofexidine reduces narcotic withdrawal symptoms.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥243 | 有现货 |
|
50MG | ¥689 | 有现货 |
|
100MG | 获取报价 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Lofexidine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Lofexidine is a selective α2-receptor agonist Lofexidine reduces narcotic withdrawal symptoms.
-
产品描述Lofexidine is a selective α2-receptor agonist Lofexidine reduces narcotic withdrawal symptoms.
-
同义词——
-
通路Angiogenesis
-
靶点Adrenergic Receptor
-
受体α2 receptor
-
研究领域Neurological Disease
-
适应症opioid withdrawal symptoms in adults
化学信息
-
CAS Number31036-80-3
-
分子量259.13
-
分子式C11H12Cl2N2O
-
纯度>98% (HPLC)
-
溶解度DMSO:62.5 mg/mL (241.19 mM)
-
SMILESCC(Oc1c(Cl)cccc1Cl)C1=NCCN1
-
化学全称2-(1-(26-dichlorophenoxy)ethyl)-45-dihydro-1H-imidazole
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Gorodetzky CW Walsh SL Martin PRet al.A phase III randomized multi-center double blind placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal[J].Drug Alcohol Depend. 2017 Jul 1;176:79-88.
产品手册
关联产品
-
JNJ-63533054
JNJ-63533054 is a potent and selective agonist of hGPR139 with an EC50 = 16 nM.
-
Medetomidine hydroch...
A potent, highly selective α2-adrenoceptor agonist with Ki of 1.08 nM; used as both a surgical anesthetic and analgesic.
-
Bupranolol
Bupranolol is an antagonist of β2-adrenergic receptor,and has been used for angina pectoris, hypertension, glaucoma, cardiac arrhythmia and as an antithrombotic.